Naresh Jain

Naresh Jain

Company: NJ Biopharmaceuticals LLC

Job title: President & Chief Executive Officer


Bio-NMR Guided Development of New Protein Degraders & their Application as ADC Effector Molecules 10:00 am

• Evaluating the use of Bio-NMR to accelerate the discovery and optimization of protein degrader effectors • These new protein degraders were further modified to be ADC effectors • These ADC constructs showed broad anti-proliferative activityRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.